Selective HDAC Inhibition for the Disruption of Latent HIV-1 Infection

Selective histone deacetylase (HDAC) inhibitors have emerged as a potential anti-latency therapy for persistent human immunodeficiency virus type 1 (HIV-1) infection. We utilized a combination of small molecule inhibitors and short hairpin (sh)RNA-mediated gene knockdown strategies to delineate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Barton, Kirston M., Archin, Nancie M., Keedy, Kara S., Espeseth, Amy S., Zhang, Yan-ling, Gale, Jennifer, Wagner, Florence F., Holson, Edward B., Margolis, David M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4138023/
https://www.ncbi.nlm.nih.gov/pubmed/25136952
http://dx.doi.org/10.1371/journal.pone.0102684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4138023/
https://www.ncbi.nlm.nih.gov/pubmed/25136952
http://dx.doi.org/10.1371/journal.pone.0102684

Ejemplares similares